EPITERNA Secures $10M Investment to Combat Aging

EPITERNA, a European-based company focused on translating scientific discoveries into extended, healthier lives, has successfully raised $10,000,000 in a recent funding round from investors. The company's core mission is to create more time that matters for both companion animals and people by addressing the fundamental challenge of ageing. Its team comprises ambitious scientists, engineers, veterinarians, and doctors who are dedicated to this complex long-term endeavor. Ageing is widely acknowledged as one of the most significant challenges of our era, serving as the major risk factor for a wide array of diseases and functional decline. While scientific research has consistently demonstrated the capacity to slow the ageing process and extend the lives of animals in laboratory settings, EPITERNA was founded with the specific aim of translating these critical discoveries into real-world applications. The company develops affordable products designed to safely slow the ageing process, with the goal of preventing age-related diseases, delaying functional decline, and ultimately extending overall life. This $10,000,000 capital infusion represents a significant milestone for EPITERNA, bolstering its capabilities to pursue its ambitious objectives. The funding secured through this investment round will be strategically deployed to accelerate the company's research and development initiatives, expand its operational infrastructure, and advance its product pipeline. This direct investment from backers underscores the company's progress and the perceived potential of its approach to longevity science. With this substantial financial backing, EPITERNA is well-positioned to further its pioneering work. The company plans to intensify its efforts in developing innovative solutions that contribute to longer, healthier, and happier lives, reinforcing its commitment to its foundational mission and its forward-looking vision for health and longevity across species.